To address inaccuracies identified in Table 2 of the original study on Ixekizumab and Tirzepatide.
Approach:
Correction Details: Baseline PASI was corrected from 'mean (SD)' to 'mean (SE),' and metabolic endpoints were reclassified as 'mean (SE)' to ensure accurate reporting.
Key Findings:
Corrections were made to the baseline PASI measurements, which were previously reported inaccurately.
Table 2 contained inaccuracies that have now been rectified.
Interpretation:
The article has been rectified online to reflect accurate statistical measures.
Conclusion:
Corrections to the baseline PASI and metabolic endpoints have been made to ensure the accuracy of the reported data.
